Need help? Our team of experienced experts is here for you with full support.
AKA-87
Rifampicin
Cat. No.
AKA-87
CAS No.
13292-46-1
MF
C43H58N4O12
MW
822.94
Rifampicin is a potent and broad spectrum antibiotic.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Storage and Shipping
References
Product Name
Rifampicin
CAS No.
13292-46-1
MF
C43H58N4O12
MW
822.94
Specification
98%
Research Area
Tuberculosis and the prophylaxis of meningococcal infection
Description
Rifampicin is a potent and broad spectrum antibiotic against bacterial pathogens. Packing: 1kg/bag; 25kg/drum or as request Availability: In Stock for prompt delivery
Documents
Certificate of Analysis (COA), API specification, Safety Data Sheet (SDS/MSDS), evidence of GMP compliance, Stability data / Stability summary, etc.
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Piriou A, et al. Fatty liver induced by high doses of rifampicin in the rat: possible relation with an inhibition of RNA polymerases in eukariotic cells. Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement. 1979;(2):333-7.
[2]. Yu J, et al. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model. The Journal of Antimicrobial Chemotherapy. 2005 Apr;55(4):528-34. Epub 2005 Mar 2.
[3]. Erokhina MV, et al. [In vitro development of rifampicin resistance in the epithelial cells]. Problemy Tuberkuleza I Bolezneĭ Legkikh. 2006;(8):58-61.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.